Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients (2022)
- Authors:
- USP affiliated authors: ROCHA, VANDERSON GERALDO - FM ; COSTA, SILVIA FIGUEIREDO - FM
- Unidade: FM
- DOI: 10.3390/antibiotics11091269
- Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS; CÉLULAS-TRONCO; TRANSPLANTE DE MEDULA ÓSSEA
- Language: Inglês
- Imprenta:
- Source:
- Título: Antibiotics-basel
- ISSN: 2079-6382
- Volume/Número/Paginação/Ano: v. 11, n. 9, article ID 1269, 8p, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GUIMARAES, Thais et al. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics-basel, v. 11, n. 9, 2022Tradução . . Disponível em: https://doi.org/10.3390/antibiotics11091269. Acesso em: 12 fev. 2026. -
APA
Guimaraes, T., Borges, I. C., Spadao, F. de S., Mariano, L., Nascimento, M. de M., Higashino, H., et al. (2022). Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics-basel, 11( 9). doi:10.3390/antibiotics11091269 -
NLM
Guimaraes T, Borges IC, Spadao F de S, Mariano L, Nascimento M de M, Higashino H, Rossi F, Rocha VG, Costa SF. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients [Internet]. Antibiotics-basel. 2022 ; 11( 9):[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/antibiotics11091269 -
Vancouver
Guimaraes T, Borges IC, Spadao F de S, Mariano L, Nascimento M de M, Higashino H, Rossi F, Rocha VG, Costa SF. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients [Internet]. Antibiotics-basel. 2022 ; 11( 9):[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/antibiotics11091269 - Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay
- Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients
- COVID-19 surveillance in a bone marrow transplantation unit: experience from a Brazilian tertiary-care teaching hospital
- Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization
- COVID-19 in hematopoietic stem-cell transplant recipients: a systematic review and meta-analysis of clinical characteristics and outcomes
- Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation
- Fatal hepatic mucormycosis in an allogeneic hematopoietic-stem cell transplanted patient: case report of a rare presentation and review of the literature
- Autologous hematopoietic stem cell transplant in a patient with leprosy: is it safe?
- Carbapenem-resistant Pseudomonas aeruginosa carrying bla(VIM-36) assigned to ST308: Indicated non-virulence in a Galleria mellonella model
- Rhodococcus hoagii bloodstream infection in an allogeneic hematopoietic stem cell transplantation patient: Case report and review of literature
Informações sobre o DOI: 10.3390/antibiotics11091269 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
